ArticleAmerican journal of translational research2026
Decursin ameliorates diabetic kidney disease by attenuating renal epithelial-mesenchymal transition via inhibition of the PI3K/Akt pathway.
Yuxin Xiong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.